These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 7474093)

  • 1. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    Huang M; Orenstein JM; Martin MA; Freed EO
    J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
    Dettenhofer M; Yu XF
    J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.
    Kondo E; Göttlinger HG
    J Virol; 1996 Jan; 70(1):159-64. PubMed ID: 8523520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
    J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
    Chiu HC; Wang FD; Chen YA; Wang CT
    J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1.
    Hemonnot B; Cartier C; Gay B; Rebuffat S; Bardy M; Devaux C; Boyer V; Briant L
    J Biol Chem; 2004 Jul; 279(31):32426-34. PubMed ID: 15155723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
    Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
    J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Demirov DG; Ono A; Orenstein JM; Freed EO
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
    Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
    J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.